Lauren Baracco

Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial

Raburn M. Mallory, Neil Formica, Susan Pfeiffer et al. · The Lancet Infectious Diseases · 2022 · 81 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19

Michael Dougan, Masoud Azizad, Peter Chen et al. · medRxiv · 2022 · 75 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

WITHDRAWN: SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer’s-like neuropathology

Wei‐Bin Shen, Montasir Elahi, James Logue et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 72 citations · Full text

Life Sciences, Neurobiology, Neuroscience +11

SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis

Marisa E. McGrath, Yong Xue, Carly Dillen et al. · Proceedings of the National Academy of Sciences · 2022 · 50 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses

Stuart Weston, Lauren Baracco, Chloe Keller et al. · Proceedings of the National Academy of Sciences · 2020 · 36 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +17